These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 4008047)
1. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Carrow EW; Domer JE Infect Immun; 1985 Jul; 49(1):172-81. PubMed ID: 4008047 [TBL] [Abstract][Full Text] [Related]
2. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Domer JE; Garner RE; Befidi-Mengue RN Infect Immun; 1989 Mar; 57(3):693-700. PubMed ID: 2917780 [TBL] [Abstract][Full Text] [Related]
7. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Cárdenas-Freytag L; Cheng E; Mayeux P; Domer JE; Clements JD Infect Immun; 1999 Feb; 67(2):826-33. PubMed ID: 9916097 [TBL] [Abstract][Full Text] [Related]
9. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis. Garner RE; Domer JE Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901 [TBL] [Abstract][Full Text] [Related]
10. Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans. Giger DK; Domer JE; McQuitty JT Infect Immun; 1978 Feb; 19(2):499-509. PubMed ID: 344213 [TBL] [Abstract][Full Text] [Related]
11. Intragastric colonization of infant mice with Candida albicans induces systemic immunity demonstrable upon challenge as adults. Domer JE J Infect Dis; 1988 May; 157(5):950-8. PubMed ID: 3283263 [TBL] [Abstract][Full Text] [Related]
12. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein. Tavares D; Ferreira P; Arala-Chaves M Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195 [TBL] [Abstract][Full Text] [Related]
13. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Fidel PL; Lynch ME; Sobel JD Infect Immun; 1993 May; 61(5):1990-5. PubMed ID: 8097493 [TBL] [Abstract][Full Text] [Related]
14. Immune responses to Candida albicans in genetically distinct mice. Hector RF; Domer JE; Carrow EW Infect Immun; 1982 Dec; 38(3):1020-8. PubMed ID: 6759403 [TBL] [Abstract][Full Text] [Related]
15. Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu. Kuruganti U; Henderson LA; Garner RE; Asofsky R; Baker PJ; Domer JE J Leukoc Biol; 1988 Nov; 44(5):422-33. PubMed ID: 3141542 [TBL] [Abstract][Full Text] [Related]
16. Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A. Domer JE; Human LG; Andersen GB; Rudbach JA; Asherson GL Infect Immun; 1993 May; 61(5):2122-30. PubMed ID: 8478102 [TBL] [Abstract][Full Text] [Related]
17. Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host. Tavares D; Salvador A; Ferreira P; Arala-Chaves M Infect Immun; 1993 May; 61(5):1881-8. PubMed ID: 8478077 [TBL] [Abstract][Full Text] [Related]